If youre consistently taking your type 2 diabetes medication but your A1C still isn't on target (less than 7 percent for most people with diabetes), you may be dealing with a phenomenon called ...

Orforglipron significantly reduced HbA1c levels by 1.3% (3mg), 1.6% (12mg), and 1.5% (36mg) compared with 0.1% in the placebo arm. Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor ...

These diet, exercise, and lifestyle tips can help keep your A1C in your target range, which can help you stay healthy and better control your type 2 diabetes.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...

CHICAGO — The investigational non-peptide small-molecule oral GLP-1 agonist orforglipron significantly reduced A1c over 40 weeks in adults with early type 2 diabetes, according to the results of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Ozempic pill reduced HbA1c by 0.83 percentage points ...

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist. Topline data were ...

The A1C test has long been considered the gold standard for measuring diabetes management success. But now, continuous glucose monitoring (CGM) technology provides a new measurement option for people ...